Trump Bought Tobacco Stocks and Raked In Industry Donations as FDA Eased Standards

• by Darius Tahir

• June 11, 2026

FDA Clears Breztri for Asthma Use

Single-inhaler triple therapy improved lung function vs dual therapy in phase 3 trials and showed rapid onset without new safety signals.

• by Kathryn Wighton

• April 28, 2026

• 2 min

FDA Cites Manufacturing Issues for Cytisinicline

Application supported by Phase 3 smoking-cessation data and long-term safety findings.

• by Kathryn Wighton

• June 22, 2026

• 3 min

Invasive NSTEMI Strategy Shows No Benefit in Frail Patients

Frailty severity may identify older patients least likely to benefit—and potentially at higher risk—with invasive management.

• by Kathryn Wighton

• May 6, 2026

• 4 min